Monday, November 16, 2026 Vol. I · No. 4
Health · Via STAT

STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions

Image: STAT

A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious adverse events reported.

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk